1.1(top 50%)
impact factor
7.0K(top 5%)
papers
21.6K(top 10%)
citations
54(top 10%)
h-index
1.1(top 50%)
impact factor
9.1K
all documents
24.7K
doc citations
75(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Collapsing Glomerulopathy in a Patient With COVID-19Kidney International Reports2020251
2Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, ItalyKidney International Reports2020195
3Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-AnalysisKidney International Reports2020184
4Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 InfectionKidney International Reports2020182
5Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and ManagementKidney International Reports2017169
6COVID-19 Vaccination and GlomerulonephritisKidney International Reports2021135
7Segmentation of Glomeruli Within Trichrome Images Using Deep LearningKidney International Reports2019126
8The Obesity Paradox in Kidney Disease: How to Reconcile It With Obesity ManagementKidney International Reports2017124
9Endemic Nephropathy Around the WorldKidney International Reports2017116
10Association of Pathological Fibrosis With Renal Survival Using Deep Neural NetworksKidney International Reports2018114
11De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19Kidney International Reports2020112
12DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary GlomerulonephritisKidney International Reports2018109
13The Renal Pathology of ObesityKidney International Reports2017108
14Bariatric Surgery and Kidney-Related OutcomesKidney International Reports2017104
15Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2Kidney International Reports2021100
16COVID-19–Associated Collapsing Glomerulopathy: An Emerging EntityKidney International Reports202096
17Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKDKidney International Reports202196
18Occupational Heat Stress and Kidney Health: From Farms to FactoriesKidney International Reports201794
19Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseKidney International Reports201792
20A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental GlomerulosclerosisKidney International Reports201789
21The Social Media Revolution in Nephrology EducationKidney International Reports201888
22Sarcopenia, Obesity, and Mortality in US Adults With and Without Chronic Kidney DiseaseKidney International Reports201786
23Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA NephropathyKidney International Reports202084
24A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular DiseaseKidney International Reports202184
25Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)Kidney International Reports202082
26Anticancer Drug-Induced Acute Kidney InjuryKidney International Reports201781
27Safety of Remdesivir in Patients With Acute Kidney Injury or CKDKidney International Reports202179
28Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic BiomarkerKidney International Reports201777
29Hyponatremia and the BrainKidney International Reports201877
30Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysisKidney International Reports201975
31Strategies for Phosphate Control in Patients With CKDKidney International Reports201974
32Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor TherapyKidney International Reports202273
33Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical TrialKidney International Reports201772
34Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative ReviewKidney International Reports201772
35Preventing CKD in Developed CountriesKidney International Reports202072
36Secondary Oxalate Nephropathy: A Systematic ReviewKidney International Reports201871
37Immune Checkpoint Inhibitors and Immune-Related Adverse Renal EventsKidney International Reports202071
38Serum Creatinine in Pregnancy: A Systematic ReviewKidney International Reports201970
39Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency CohortKidney International Reports201669
40Constipation in CKDKidney International Reports202069
41Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney DiseaseKidney International Reports201768
42IgA Vasculitis With Nephritis (Henoch−Schönlein Purpura) in a COVID-19 PatientKidney International Reports202068
43CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and ManagementKidney International Reports202067
44A Systematic Review of COVID-19 and Kidney TransplantationKidney International Reports202166
45Roxadustat for CKD-related Anemia in Non-dialysis PatientsKidney International Reports202165
46Kidney Diseases in Agricultural Communities: A Case Against Heat-Stress NephropathyKidney International Reports201863
47Natural History and Genotype–Phenotype Correlation in Female X-Linked Alport SyndromeKidney International Reports201762
48APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and RationaleKidney International Reports202062
49Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA VasculitisKidney International Reports201861
50Current and Investigational Therapeutics for Fabry DiseaseKidney International Reports202061